Xenon Pharma
XENE35.4602.85% ( -1.040 )
Xenon Pharma (XENE)
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patie...
- Open
- 36.250
- High
- 36.620
- Low
- 35.280
- Prev. Close
- 36.500
- Volume
- 305.74K
- Turnover
- 10.88M
- Avg Price
- 35.574
- Bid/Ask Ratio
- -92.45%
- Amplitude
- 3.67%
- 52wk High
- 72.660
- Volume Ratio
- 0.54
- Turnover Ratio
- 0.34%
- 52wk Low
- 33.380
- Float Mkt Cap
- 3.22B
- Market CapUSD
- 3.43B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -4.23
- EPSDynamic
- -4.40
- EPSStatic
- --
- BVPS
- 12.83
- P/B
- 2.76
- Circulating Supply
- 90.90M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 96.84M
- Min lot size
- 1
- Currency
- USD
Xenon Pharma Analyst Rating
View moreForecast & Rating
Oct 12, 2026Price forecast
$71.94102.88%
Forecast & RatingStrong buy
19analysts
- Strong buy78.95%
- Buy15.79%
- Hold5.26%
- Sell0.00%
- Strong sell0.00%
News
- Global Report ·
A Ticker Is Not a Business: Reading the Market's Long Tail
- Tip Ranks ·
Wells Fargo Reaffirms Their Buy Rating on Xenon (XENE)
- Global Report ·
ECARX Closes Flyme Deal as the Long Bond Pushes Past 5.3%
- Global Report ·
Beyond the Divestiture: How Specialization Defines 2026's Biopharma Winners
- Global Report ·
Sector Reshuffle: AI Bets and Boardroom Revolutions Drive Corporate Turnarounds
- benzinga_article ·
Alpha Buying: 4 Biotech Stocks Insiders Are Betting On
